I just checked Bloomberg, and Merrill says that
HMA looks great. HMA presented at their Health Care
Conference yesterday, and HMA's CEO said that this quarter
would be the 42nd consecutive Q with Earnings growth.
Merrill analysts raised their near-term Price Target to
18 on HMA, saying that HMA continues to expand,
execute, and impress.
anyone know extent of current short interest in
HMA. I'm already heavily into this stock and will buy
more at $11.00,I guess we're seeing ,once again, heavy
institutional selling.For everyone who sells for any reason
there's someone else who's buying because they think it's
going up.This is not for the faint-hearted. The real
pros hold more than 80% of this stock, insiders hold
another 10%( they're holding on, having seen their
holdings go from $25 to $12), smallplayers just have to
hold on. Good luck longs
Nice to hear that you made profit in health care
sector before. Better invest more in HMA if you want to
become more rich. It is a good investment in short term
as well as in long term. And offcourse if you have
shorted HMA then better buy it back.
What I believe
is that you want to buy HMA but at a lesser price
than current. You know it is a chicken giving golden
eggs. What you don't know is HMA is already far
undervalued and far oversold.
Friends this is a golden
opportunity to buy HMA. I don't feel this is going to go down
further. BUY BUY BUY.
Having 20 + years experience in the healthcare
field has made me one very sharp hombre. I have only
twice invested in healthcare issues and twice I have
made a good profit. (Columbia and HMA).
Rogers said: "You gotta know when to hold em and know
when to fold em".
I couldn't resist the moment to post another
"There is always
something to worry about. Avoid weekend thinking and ignore
the latest dire predictions of newscasters. Sell a
stock because the company's fundamentals deteriorate,
not because the sky is falling."
Last time I
checked HMA's fundamentals are not deteriorating.
"The old ways of determining the success of
health care organizations are no longer valid," said
Prince, who is a professor of health services management,
accounting and information systems at the J.L. Kellogg
Graduate School of Management of Northwestern University.
"New measures that more accurately reflect today's
health care system are needed."
A Dec. 8 AHA News
feature story on the issue, Hitting the books: Will your
hospital survive? Margins can't tell the whole story,
focuses on the need to re-examine how government,
communities and hospitals perceive the relative financial
well-being of health care institutions.
By plugging in data from certified financial
statements, hospitals and other institutions can gauge their
financial status The indicators are:
Cash Flow to
Net Patient Revenue
Cash Flow to Total
Return to Net Operating Revenue
Case-mix Index for Medicare
Inpatients in the Medicare Prospective-Payment System
Average Age of Plant and Equipment
As I am sure you don't have a clue as to how to
analyze a hospital corps. balance sheet (neither do most
"Analysts"...I will leave you with a few pearls of
1. Stay away from hospital stock....too volatile. My
best advice. If you care not to take it read
2. Don't believe that simple numbers expressing
growth or profit amount to proof positive that you have
found "value" in a hospital offering. In HMA's case 21%
growth begs the question....21% of what? Hma now owns or
leases 34 or so hospitals. Columbia owns 330+ hospitals.
Yet the total number of beds in Hma facilities are
less then 3% of the total beds managed by Columbia.
HMA is a VERY SMALL HOSPITAL CORPORATION. You know
that if you own 1 of something and aquire a second you
have grown by 100%. For HMA 21% growth equals about 90
hospital beds. Keep it in perspective. They do not have
mass to sustain in a financially tight
3. Hospitals keep the most slippery sets of books
imaginable. Hospitals defy normal corporate accounting
practices. There profits and losses do not depend upon
normal market forces. SUPPLY AND DEMAND ARE NOT THE
PRIMARY FORCES AT WORK DEFINING THE BOTTOM
4. A good question to ask of Hma is how will the
company fair in a competitive environment that they are
now moving into with recent aquisitions. I suggest to
you that they will not do well as they are too
centralized and corporately inflexible to compete in local
markets. ( If you review their proprietary management plan
the want to raise prices within a year of acquiring a
facility....not easy to do when you face competition. They simply
haven't had to compete in the past and they do not know
how to go about it. The learning curve will be real
So as not to leave you empty handed I offer you a
way to figure out how well HMA is really doing. When
you discover that you still cannot really g
CYSI -- ANYWAY, WON'T BORE YOU WITH THE DETAILS,
BUT READ THE LAST FOUR NEWS STORIES ON CYSI AND
YOU'LL SEE WHY UP 80% LAST 3 DAYS AND HAS POTENTIAL,
BASED ON SIMPLE FUTURE EARNINGS LATER IN YEAR THAT ARE
BASICALLY PRE-ANNOUNCED IN THE NEWS RELEASES, WHY CYSI WILL
BE A 10-BAGGER (1000%) GAIN. HERE'S THE
8-Jun-99 11:50:59 Thomson I-Watch shows that
Health Management Assoc
from institutional brokers on both the buy and
side in the
pre-trade market. The trading data
shows that these brokers are
with execution - over 2.4 million shares have traded
compared to average daily volume of 1.4
million shares. Of today's
almost 95% of
was related to block transactions. The stock was
on a sell
imbalance this morning, opening down
$1/2 on a 847,000 share trade.
MONICA, SMITH BARNEY
STOCKPICKS YOU ASKED ME LAST
http://www.angelfire.com/mo/sbtech MONICA, I LOVE YOU!
John R. Schroer is scheduled to be the special
guest on Wall
Street Week w/Luis Rukeyser. He is the
portfolio manager for Invesco Health Sciences Fund. I don't
know what his opinion of HMA is. His comments on the
health care industry should be interesting regardless of
whether HMA is mentioned.